Emer M Brady Selected Research

ECHO protocol

1/2021

A comparison of liver fat fraction measurement on MRI at 3T and 1.5T.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emer M Brady Research Topics

Disease

7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2015
2	Body Weight (Weight, Body) 03/2022 - 01/2020
2	Weight Loss (Weight Reduction) 01/2020 - 01/2015
2	Obesity 01/2020 - 07/2019
2	Overweight 07/2019 - 01/2015
1	Diabetic Cardiomyopathies 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hypertrophy 01/2022
1	Inflammation (Inflammations) 01/2022
1	Insulin Resistance 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2012

Drug/Important Bio-Agent (IBA)

3	Liraglutide FDA Link 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
2	Insulin (Novolin)FDA Link 01/2022 - 01/2020
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2020 - 01/2020
1	LipidsIBA 03/2022
1	CalciumIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Advanced Glycation End ProductsIBA 01/2022
1	TESIBA 01/2021
1	MicronutrientsIBA 01/2021
1	empagliflozinIBA 01/2020
1	SugarsIBA 07/2019
1	Exenatide (Byetta)FDA Link 01/2015
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2015
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2015
1	CholesterolIBA 04/2012

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2015
1	Caloric Restriction 01/2022
1	ECHO protocol 01/2021
1	Glycemic Control 01/2020